Bharat Biotech: News
26 Jan 2023COVID-19
Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh on Thursday launched Bharat Biotech's iNCOVACC, which is reportedly India's first intranasal COVID-19 vaccine.
27 Dec 2022COVID-19
Hyderabad-based vaccine maker Bharat Biotech on Tuesday announced the price of its recently-approved intranasal COVID-19 vaccine, named iNCOVACC.
23 Dec 2022COVID-19
The Centre has given its nod to Bharat Biotech's nasal vaccine: iNCOVACC. It has been included in the COVID-19 vaccination program and has been approved to be used as a heterologous booster from today.
23 Dec 2022Vaccine
Union Health Minister Mansukh Mandaviya informed on Friday that the Centre has approved Bharat Biotech's nasal vaccine to be used as a heterologous booster.
07 Sep 2022COVID-19
Bharat Biotech's nasal spray vaccine for immunization against COVID-19 has been approved by the Central Drugs Standard Control Organisation (CDSCO).
06 Sep 2022Mansukh Mandaviya
The nasal vaccine for immunization against COVID-19, developed by Hyderabad-based vaccine maker Bharat Biotech, has received the approval of the Central Drugs Standard Control Organisation (CDSCO).
15 Aug 2022United Kingdom
The manufacturing body of the made-in-India Covaxin is only steps away from releasing its intranasal vaccine for the virus.
19 Jun 2022World Health Organization
The phase 3 clinical trials of Bharat Biotech's COVID-19 nasal vaccine have been completed, according to Dr. Krishna Ella, the company's Chairman and Managing Director.
29 Apr 2022World Health Organization
The Ministry of External Affairs (MEA) on Friday denied reports that it had asked Bharat Biotech to address issues to avoid the cancellation of the World Health Organization's (WHO) emergency approval for its COVAXIN.
22 Apr 2022Drugs Controller General of India
Bharat Biotech's COVID-19 vaccine, COVAXIN, is likely to get the Drugs Controller General of India's (DCGI) nod for use among children aged two to 12 years.
03 Jan 2022COVID-19
Pharmaceutical firm Bharat Biotech on Monday said it plans to increase the supply of its COVID-19 vaccine COVAXIN to up to eight crore doses a month, starting February.
01 Dec 2021Zydus Cadila
The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.
03 Nov 2021World Health Organization
The World Health Organization (WHO) on Wednesday granted Emergency Use Listing (EUL) to COVAXIN.
01 Nov 2021India
Australia on Monday accepted India's indigenous vaccine, COVAXIN, as a "recognized" vaccine for the purpose of travel to the country.
19 Oct 2021India
The World Health Organization (WHO) Monday clarified the reason behind the delay in COVAXIN's emergency use listing (EUL), stating that it is expecting more information from Bharat Biotech on its COVID-19 vaccine.
12 Oct 2021Health & Wellness
The Subject Expert Committee (SEC) on COVID-19 has recommended the approval of Bharat Biotech's COVAXIN for children aged between two and 18 years.
03 Oct 2021World Health Organization
Bharat Biotech has reportedly submitted trial data of its COVID-19 vaccine, COVAXIN, for children aged under 18 years to the Drugs and Comptroller General of India (DCGI).
21 Sep 2021COVID-19
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, COVAXIN for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman, and Managing Director of Bharat Biotech International Ltd., Krishna Ella said.
17 Sep 2021World Health Organization
Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine COVAXIN to the World Health Organization for EUL and is awaiting feedback from the global health watchdog.
28 Aug 2021Indian Council of Medical Research (ICMR)
A single dose of Bharat Biotech's COVAXIN in previously COVID-19-infected individuals elicits a similar antibody response as obtained with two doses of the vaccine in those without a previous history of the disease, according to an ICMR study.
24 Jul 2021Brazil
Bharat Biotech on Friday announced the termination its agreement with two foreign firms for the supply of COVAXIN to Brazil.
23 Jul 2021Coronavirus
Bharat Biotech on Friday said it has committed to supply over 500 million doses of COVAXIN to the Centre under the countrywide immunization program.
28 May 2021COVID-19 Vaccine
Hester Biosciences on Thursday said a memorandum of understanding (MoU) has been signed between Hyderabad-based vaccine maker Bharat Biotech and Gujarat COVID-19 Vaccine Consortium (GCVC) for contract manufacturing the drug substance for COVAXIN.
03 Jul 2021COVID-19
COVAXIN, the coronavirus vaccine developed by India's Bharat Biotech, is overall 77.8 percent effective, the company said in a statement today, sharing the final analysis of its phase three trial data.
30 Jun 2021Vaccine
Hyderabad-based pharmaceutical company Bharat Biotech denied any wrongdoing on its part after Brazil suspended a $324 million contract for doses of its COVID-19 vaccine COVAXIN.
22 Jun 2021Vaccine
COVAXIN, the COVID-19 vaccine developed by Bharat Biotech, has been found 77.8% effective against the viral disease, Phase III trial data reportedly revealed.
16 Jun 2021Vaccine
COVAXIN, the indigenous COVID-19 vaccine produced by Bharat Biotech, does not contain calf serum, the Union Health Ministry clarified on Wednesday.
07 Jun 2021All India Institute Of Medical Sciences (AIIMS)
The All India Institute of Medical Sciences (AIIMS), Delhi will begin screening children from Monday to conduct clinical trials of the indigenously developed, Bharat Biotech's vaccine against COVID-19, COVAXIN.
29 May 2021Ministry of Health and Family Welfare
The Health Ministry has slammed news about unaccounted COVAXIN doses as "unfound media reports" adding that these reports are incorrect and not supported by full information on the matter.
28 May 2021Aam Aadmi Party (AAP)
The AAP on Friday alleged that the Centre is creating artificial scarcity of COVID-19 vaccines to benefit Bharat Biotech and Serum Institute of India, a charge termed by the Delhi BJP as unfounded.
24 May 2021World Health Organization
Bharat Biotech, the pharmaceutical firm behind India's first indigenous COVID-19 vaccine COVAXIN, may begin trials on children in June and is expecting to receive the license in the third quarter of this year.
21 May 2021India
Hyderabad-based firm Bharat Biotech has said it will scale up the manufacturing capacity of its coronavirus vaccine, COVAXIN, by an additional 200 million (20 crore) doses per year.
13 May 2021COVAXIN
India's apex drug regulator has granted permission for conducting the Phase II/III clinical trial of Bharat Biotech's COVAXIN in the age group of 2 to 18 years, the Union Health Ministry said on Thursday. The trial will be conducted on 525 healthy volunteers.
12 May 2021Bulandshahr
To accelerate the production of COVAXIN—the indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech—amid severe vaccine shortage in India, the Centre on Wednesday reportedly gave its nod for production of COVAXIN at government-owned Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh's Bulandshahr.
12 May 2021Vaccine
In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.
01 May 2021Madhya Pradesh
A truck carrying 2.40 lakh doses of COVAXIN worth Rs. 8 crore was left parked for nearly 12 hours after its driver went missing under mysterious circumstances in Madhya Pradesh's Narsinghpur district.
29 Apr 2021Vaccine
Hyderabad-based pharmaceutical company Bharat Biotech on Thursday reduced the price of its COVID-19 vaccine, COVAXIN, for state governments.
20 Apr 2021COVID-19
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, COVAXIN, to 700 million doses per annum, the vaccine maker said on Tuesday.
31 Mar 2021Brazil
The Brazilian health regulator Anvisa denied permission to import Bharat Biotech's COVID-19 vaccine COVAXIN into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing Practice requirements.
20 Mar 2021Nepal
Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's COVAXIN, becoming the third country to approve India's indigenously developed COVID-19 vaccine.
09 Mar 2021COVAXIN
COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has shown better reactogenicity and safety, Phase II trial interim data published in The Lancet journal showed.
04 Mar 2021Delhi High Court
The Delhi High Court on Thursday pulled up the central government over restricted COVID-19 vaccinations in India, even as vaccine exports to other nations continue.
03 Mar 2021Vaccine
COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has been found to have 81% interim efficacy against preventing infections, the company said on Wednesday.
27 Jan 2021Coronavirus
COVAXIN, developed by Bharat Biotech, has the ability to neutralize the UK variant of the coronavirus, according to a pre-print review by bioRxiv, a free online archive and distribution service for unpublished pre-prints in the life sciences.
24 Jan 2021Vaccine
As the first phase of COVID-19 vaccinations is underway in India, nearly 16 lakh healthcare and frontline workers have been inoculated, government data showed.
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
19 Jan 2021Coronavirus
Bharat Biotech secured a fresh Letter of Comfort from the Centre for 45 lakh doses of its COVID-19 vaccine, COVAXIN.
19 Jan 2021Vaccine
Two days after India started its coronavirus vaccination program, Hyderabad-based Bharat Biotech released guidelines revealing who should receive shots of COVAXIN.
17 Jan 2021Madhya Pradesh
The COVID-19 Vaccine Intelligence Network (Co-WIN) platform suffered several glitches on the first day of India's vaccination drive.
17 Jan 2021Maharashtra
On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.
13 Jan 2021Coronavirus
Bharat Biotech, on Wednesday, said that it has successfully air-shipped its COVID-19 vaccine COVAXIN to eleven cities in India in the early hours. It has also donated 16.5 lakh doses to the Centre.
11 Jan 2021Narendra Modi
In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.
09 Jan 2021Madhya Pradesh
A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.
08 Jan 2021Oxford University
India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).